MedTrace Logo

Progress Pediatric Study

NCT01328288 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 840

Last updated 2016-02-22

No results posted yet for this study

Summary

The purpose of this study is to study the HIV disease progression in HIV-infected Thai children.

Conditions

Interventions

DRUG

standard ART according to the Thai Ministry of Public Health national guidelines

Patients may receive any of the standard regimens. These regimens are recommended in the Thai Ministry of Public Health National guidelines for the treatment of HIV in children. Change of treatment will be according to the treating physicians.

Sponsors & Collaborators

  • Bamrasnaradura Infectious Diseases Institute

    collaborator OTHER_GOV

  • Mahidol University

    collaborator OTHER

  • Chiangrai Prachanukroh Hospital

    collaborator OTHER

  • Sanpatong Hospital

    collaborator UNKNOWN

  • The HIV Netherlands Australia Thailand Research Collaboration

    lead OTHER

Principal Investigators

  • Wisit Prasithsirikul, MD · Bamrasnaradura infectious disease institute

  • Rawiwan Hansudewechakul, MD · Chiangrai Prachanukroh Hospital

  • Wirat Klinbuayam, MD · Sanpatong Hospital

  • Jintanat Ananworanich, MD, PhD · HIV-NAT, Thai Red Cross - AIDS Research Centre

  • Kulkanya Chokephaibulkit, MD · Mahidol University

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01328288 on ClinicalTrials.gov